Ok Biotech Co., Ltd.(TW:4155)
NT$16.90-0.60 (-3.43%)
TW:4155
Ok Biotech Co., Ltd. financials statements
NT$16.90
At close:-0.60 (-3.43%)
Ok Biotech Co., Ltd. (4155) Income Statement
Ok Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), Ok Biotech Co., Ltd.'s total revenue was NT$436.13M, an increase of 2.20% from the same quarter last year. In Q2, Ok Biotech Co., Ltd.'s net income was NT$48.16M. See Ok Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.56B | NT$ 1.67B | NT$ 1.19B | NT$ 1.48B | NT$ 1.26B | |
| NT$ 429.25M | NT$ 275.65M | NT$ 196.88M | NT$ 344.96M | NT$ 186.83M | |
| NT$ 321.36M | NT$ 235.18M | NT$ 196.88M | NT$ 204.82M | NT$ 176.98M | |
| Depreciation and Amortization | NT$ 93.61M | NT$ 72.42M | NT$ 75.55M | NT$ 67.88M | NT$ 55.88M |
| NT$ 201.51M | NT$ 205.76M | NT$ 87.24M | NT$ 247.47M | NT$ 85.45M | |
| NT$ 107.89M | NT$ 57.21M | NT$ -12.06M | NT$ 211.62M | NT$ 49.31M | |
| NT$ -4.03M | NT$ 69.90M | NT$ 20.09M | NT$ 73.78M | NT$ 38.05M | |
| NT$ 103.87M | NT$ 127.11M | NT$ 8.03M | NT$ 175.59M | NT$ 46.14M | |
| NT$ 82.45M | NT$ 93.97M | NT$ 2.95M | NT$ 143.46M | NT$ 31.42M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.58 | NT$ 0.66 | NT$ 0.02 | NT$ 1.34 | NT$ 0.30 |
| Diluted EPS | NT$ 0.57 | NT$ 0.64 | NT$ 0.02 | NT$ 1.14 | NT$ 0.26 |
| Weighted Average Shares Outstanding | 167.47M | 142.58M | 128.24M | 106.68M | 105.90M |
| Weighted Average Shares Outstanding (Diluted) | 167.47M | 146.41M | 128.40M | 132.38M | 120.40M |
Currency in TWD
